The FDA-approved titration schedule for Zepbound begins at 2.5 mg weekly, with increases no sooner than every 4 weeks through sequential doses of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to a maximum maintenance dose of 15 mg weekly, depending on individual response and tolerability
What is a Pre-Workout
Discontinue use if any irritation occurs
LDL cholesterol may decrease
Semaglutide treatment commenced at 0.25 mg per week for the initial 4 weeks using a pre-filled pen injector, with a fixed-dose escalation every 4 weeks until reaching the maintenance dose of 2.4 mg by week 16 (lower maintenance doses allowed if 2.4 mg was intolerable for participants)
Current evidence shows that biological factors such as sex (with women tending to lose more weight), the presence of type 2 diabetes (associated with less weight loss), age (with older individuals typically losing less weight), and fatty liver disease (also linked to reduced weight loss) all play a significant role